Global Medical REIT Inc. Announces Proposed Public Offering of Series B Preferred Stock

Core Viewpoint - Global Medical REIT Inc. has announced a proposed public offering of its Series B Cumulative Redeemable Preferred Stock, aiming to utilize the net proceeds for general corporate purposes, including funding new acquisitions and repaying debt [1][3]. Offering Details - The offering will include a 30-day option for underwriters to purchase additional shares to cover over-allotments [1]. - The Series B Preferred Stock is intended to be listed on the New York Stock Exchange under the ticker symbol "GMRE-PrB" [2]. - The offering is made under the company's shelf registration statement, which was declared effective by the SEC on April 4, 2024 [3]. Use of Proceeds - The net proceeds from the offering are expected to be used for general corporate purposes, which may include funding new acquisitions and repaying existing indebtedness [1]. Company Overview - Global Medical REIT Inc. operates as a net-lease medical REIT, acquiring healthcare facilities and leasing them to physician groups and healthcare systems [5].